The Role of Immune Correlates and Surrogate Markers in the Development of Vaccines and Immunotherapies for Plague

Por Williamson, E. D.
Publicado em 2012

Protecting against plague: towards a next-generation vaccine

Por Williamson, E D, Oyston, P C F
Publicado em 2013

Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague.

Por Titball, R W, Howells, A M, Oyston, P C, Williamson, E D
Publicado em 1997

Anti-idiotypic antibody-induced protection against Clostridium perfringens type D.

Por Percival, D A, Shuttleworth, A D, Williamson, E D, Kelly, D C
Publicado em 1990

Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization.

Por Hill, J, Leary, S E, Griffin, K F, Williamson, E D, Titball, R W
Publicado em 1997

Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague.

Por Leary, S E, Williamson, E D, Griffin, K F, Russell, P, Eley, S M, Titball, R W
Publicado em 1995

Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague.

Por Oyston, P C, Williamson, E D, Leary, S E, Eley, S M, Griffin, K F, Titball, R W
Publicado em 1995

An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model

Por WILLIAMSON, E D, VESEY, P M, GILLHESPY, K J, ELEY, S M, GREEN, M, TITBALL, R W
Publicado em 1999

The fraction 1 and V protein antigens of Yersinia pestis activate dendritic cells to induce primary T cell responses

Por Kingston, R, Burke, F, Robinson, J H, Bedford, P A, Jones, S M, Knight, S C, Williamson, E D
Publicado em 2007

Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.

Por Anderson, G W, Leary, S E, Williamson, E D, Titball, R W, Welkos, S L, Worsham, P L, Friedlander, A M
Publicado em 1996

Conjugation of Y. pestis F1-antigen to gold nanoparticles improves immunogenicity

Por Gregory, A. E., Williamson, E. D., Prior, J. L., Butcher, W., Thompson, I. J., Shaw, A. M., Titball, R. W.
Publicado em 2012

Epitope mapping of the alpha-toxin of Clostridium perfringens.

Por Logan, A J, Williamson, E D, Titball, R W, Percival, D A, Shuttleworth, A D, Conlan, J W, Kelly, D C
Publicado em 1991

Probing molecular interactions in intact antibody: antigen complexes, an electrospray time-of-flight mass spectrometry approach.

Por Tito, M A, Miller, J, Walker, N, Griffin, K F, Williamson, E D, Despeyroux-Hill, D, Titball, R W, Robinson, C V
Publicado em 2001

Exposure to anthrax toxin alters human leucocyte expression of anthrax toxin receptor 1

Por Ingram, R J, Harris, A, Ascough, S, Metan, G, Doganay, M, Ballie, L, Williamson, E D, Dyson, H, Robinson, J H, Sriskandan, S, Altmann, D M
Publicado em 2013

Human Immune Response to a Plague Vaccine Comprising Recombinant F1 and V Antigens

Por Williamson, E. D., Flick-Smith, H. C., LeButt, C., Rowland, C. A., Jones, S. M., Waters, E. L., Gwyther, R. J., Miller, J., Packer, P. J., Irving, M.
Publicado em 2005

Immunogenicity of Recombinant Protective Antigen and Efficacy against Aerosol Challenge with Anthrax

Por Williamson, E. D., Hodgson, I., Walker, N. J., Topping, A. W., Duchars, M. G., Mott, J. M., Estep, J., LeButt, C., Flick-Smith, H. C., Jones, H. E., Li, H., Quinn, C. P.
Publicado em 2005